IP Library › Granted Patent US 11,504,454
Granted Patent B2
US 11,504,454 · App. 14/714,685 · Granted Nov 22, 2022

Biocompatible surfaces and devices incorporating such surfaces

Inventors: Keith A. Knisley (Flagstaff, AZ); Vishnu T. Marla (Newark, DE); Rachel Radspinner (Flagstaff, AZ); Paul A. Silvagni (Flagstaff, AZ); Jason J. Strid (Elkton, MD); Michael J. Vonesh (Flagstaff, AZ)
Assignee: W. L. Gore & Associates, Inc.
A61L31/06A61F2/0077A61F2/82A61L31/048A61L31/10A61L31/146A61L31/16A61L33/007A61L33/064A61F2002/009A61L2300/416A61L2300/42A61L2400/12A61L2400/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,504,454
App. No.
14/714,685
Granted
Nov 22, 2022
Kind
B2
Abstract

The invention is an improved biocompatible surface for a variety of medical purposes. The biocompatible surface employs a unique tight microstructure that demonstrates enhanced cellular response in the body, particularly when placed in contact with blood. As a blood contact surface, the present invention can be beneficially employed in a wide variety of implantable devices and in many other devices and equipment that come in contact with blood.

Claims (26)

1. A blood contact surface comprising:

a synthetic biomaterial having a microstructure of interconnected fibrils morphologically analogous to microstructure of a natural human fibrin mat, wherein the synthetic material comprises a fluoropolymer, and wherein the fluoropolymer is expanded and comprises fibrils and nodes with an average internodal distance of less than about 5 microns.

2. The blood contact surface of claim 1 wherein the expanded fluoropolymer comprises expanded polytetrafluoroethylene.

3. A blood contact surface comprising

a fluoropolymer having a node and fibril microstructure substantially as shown in FIG. 4 .

4. The blood contact surface of claim 3 wherein the fluoropolymer comprises copolymers of tetrafluoroethylene.

5. The blood contact surface of claim 3 wherein the fluoropolymer comprises polytetrafluoroethylene.

6. An implantable medical device that comprises the blood contact surface of claim 3 .

7. A blood contact surface comprising

a fluoropolymer having a node and fibril microstructure morphology substantially as shown in FIG. 5 .

8. The blood contact surface of claim 7 wherein the fluoropolymer comprises copolymers of tetrafluoroethylene.

9. The blood contact surface of claim 7 wherein the fluoropolymer comprises polytetrafluoroethylene.

10. An implantable medical device that comprises the blood contact surface of claim 7 .

11. A blood contact surface comprising

a fluoropolymer having a node and fibril microstructure morphology substantially as shown in FIG. 22 .

12. The blood contact surface of claim 11 wherein the fluoropolymer comprises copolymers of tetrafluoroethylene.

13. The blood contact surface of claim 11 wherein the fluoropolymer comprises polytetrafluoroethylene.

14. An implantable medical device that comprises a blood contact surface of a synthetic biomaterial having a microstructure of interconnected fibrils morphologically analogous to microstructure of a natural human fibrin mat, wherein the synthetic material comprises a fluoropolymer, and wherein the fluoropolymer is expanded and comprises fibrils and nodes with an average internodal distance of less than about 5 microns.

15. A blood contact surface that comprises a synthetic biomaterial having a microstructure of interconnected fibrils morphologically analogous to microstructure of a natural human fibrin mat, said blood contact surface comprising an implantable vascular graft, wherein the synthetic biomaterial comprises a fluoropolymer, and wherein the fluoropolymer is expanded and comprises fibrils and nodes with an average internodal distance of less than about 5 microns.

16. A blood contact surface of a synthetic biomaterial having a microstructure of interconnected fibrils morphologically analogous to microstructure of a natural human fibrin mat, said blood contact surface comprising an implantable stent-graft, wherein the synthetic biomaterial comprises a fluoropolymer, and wherein the fluoropolymer is expanded and comprises fibrils and nodes with an average internodal distance of less than about 5 microns.

17. A blood contact surface of a synthetic biomaterial having a microstructure of interconnected fibrils morphologically analogous to microstructure of a natural human fibrin mat;

wherein the microstructure has an internodal distance in a first x direction that is approximately the same as an internodal distance in a perpendicular y direction.

18. A blood contact surface of a synthetic biomaterial having a microstructure of interconnected fibrils morphologically analogous to microstructure of a natural human fibrin mat;

wherein the microstructure has an internodal distance in a first x direction and an internodal distance in a perpendicular y direction; and

wherein a ratio of internodal distances in the x and y directions comprises about 1:1.

19. The blood contact surface of claim 17 wherein a ratio of internodal distances in the x and y directions comprises about 1:1.

Continuity (3)
Division 13773937 · Feb 22, 2013
Provisional Application 61606020 · Mar 2, 2012
Related Publication 20150258250A1 · Sep 17, 2015